Clinical Trial Update: Sunitinib in Never-Smokers With Lung Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sunitinib in never-smokers with lung adenocarcinoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-09-04